TTNP Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development of pharmaceutical products.

As of 06/18/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/18/1996
Outstanding shares:  9,864,068
Average volume:  129,692
Market cap:   $24,364,248
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    888314606
ISIN:        US8883146065
Sedol:      BLGZC09
Valuation   (See tab for details)
PE ratio:   -1.66
PB ratio:   156.25
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy